Roche and Glenmark settle cancer drug patent row

04-01-2016

Roche and Glenmark settle cancer drug patent row

lucarista / shutterstock.com

Roche has settled its patent litigation dispute with India-based Glenmark Pharmaceuticals centring on cancer drug Tarceva (erlotinib).


Roche, Glenmark, Tarceva, patent, lung cancer

LSIPR